New York City-based Redpin Therapeutics, Inc., a chemogenetics company, has secured $15.5 million in funding. The lead backers were 4BIO Capital and Arkin Bio Ventures.
Source: Press Release
Redpin Therapeutics snags $15.5m
New York City-based Redpin Therapeutics, Inc., a chemogenetics company, has secured $15.5 million in funding.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: